• Register
  • Login
  • Subscribe
  • Contact Us

Maximizing Access to Research Careers (T34 - Clinical Trial not Allowed)

USARFP notice for Maximizing Access to Research Careers (T34 - Clinical Trial not Allowed). The reference ID of the tender is 50549485 and it is closing on 26 May 2023.

Tender Details

  • Country: USA
  • Summary: Maximizing Access to Research Careers (T34 - Clinical Trial not Allowed)
  • UST Ref No: 50549485
  • Deadline: 26 May 2023
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: PAR-21-147
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Tender are invited for Maximizing Access to Research Careers (T34 - Clinical Trial Not Allowed)
    CFDA Number : 93.859 -- Biomedical Research and Research Training
    Cost Sharing or Matching Requirement : No
    Closing Date for Applications: May 26, 2023
    Posted Date : Feb 23, 2021
    Description: The goal of the Maximizing Access to Research Careers (MARC) program is to develop a diverse pool of undergraduates who complete their baccalaureate degree, and transition into and complete biomedical, research-focused higher degree programs (e.g., Ph.D. or M.D./Ph.D). This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring, and career development elements to prepare trainees for the completion of research-focused higher degree programs in biomedical fields. This program is limited to applications from training programs at research-intensive institutions (i.e., those with a 3-year average of NIH Research Project Grant funding equal to or above $7.5 million total costs).
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Maximizing Access to Research Careers (T34 - Clinical Trial not Allowed) - USA Tender

The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Maximizing Access to Research Careers (T34 - Clinical Trial not Allowed). This tender is published on USARFP under UST Ref No: 50549485 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-05-26.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

USARFP Features

USARFP Features

Fresh and verified Tenders from USA. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting USARFP !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from USA in your email inbox.

  Chat with us